Menu
Back to Journals » International Journal of General Medicine » Volume 15
Integrated Management Strategies for Epidermolysis Bullosa: Current Insights [Corrigendum]
Authors Sait H, Srivastava S, Saxena D
Received 21 June 2022
Accepted for publication 21 June 2022
Published 27 June 2022 Volume 2022:15 Pages 5807—5808
Sait H, Srivastava S, Saxena D. Int J Gen Med. 2022;15:5133–5144.
The authors have advised that the Figures were labelled incorrectly and Figure 1 should appear in the paper as Figure 2 and vice versa.
Page 5134, Figure 1, the correct figure is shown in Download Article.
Figure 1 The 4 layers of skin with dermo-epidermal junctions and corresponding genes involved in the maintenance of their integrity. Basal keratinocytes secrete KRT5 and KRT14, which form the intermediate filaments and interact with other cytoskeletal proteins in epidermis and lamina lucida to provide integrity and adhesion. Gain of function mutations in KLHL24 gene leads to breakdown of intermediate filaments.
Page 5137, Figure 2, the correct figure is shown in Download Article.
Figure 2 Various novel therapeutic strategies that are being explored in management of epidermolysis bullosa.
Abbreviations: AON, Anti sense oligonucleotide; SMaRT, Spliceosome-mediated RNA trans-splicing.
The authors apologize for the error.
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.